Kim-Hafken Tina
Conseiller Juridique Général chez RAIN ONCOLOGY INC.
Profil
Kim-Hafken Tina is currently working as Vice President-Regulatory Affairs at Rain Oncology, Inc. Previously, she worked as Senior Director-Regulatory Affairs at Seagen Inc. She completed her undergraduate degree from The Johns Hopkins University and the University of Kansas.
Postes actifs de Kim-Hafken Tina
| Sociétés | Poste | Début |
|---|---|---|
| RAIN ONCOLOGY INC. | Conseiller Juridique Général | - |
Anciens postes connus de Kim-Hafken Tina
| Sociétés | Poste | Fin |
|---|---|---|
| SEAGEN INC. | Conseiller Juridique Général | - |
Formation de Kim-Hafken Tina
| The Johns Hopkins University | Undergraduate Degree |
| University of Kansas | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Rain Oncology, Inc.
 Rain Oncology, Inc. BiotechnologyHealth Technology Rain Oncology, Inc. is a clinical-stage precision oncology company, which focuses on developing and implement the precision oncology therapies for patients suffering from cancer. The company was founded by Avanish Vellanki and Robert Doebele in April 2017 and is headquartered in Newark, CA. | Health Technology |
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
